CNT-CNS-3

CNT-CNS-3 is a peptide-based synthetic immunomodulator developed by Centurion Pharma for the treatment of nervous system disorders. It is formulated as a pre-filled syringe (PFS) for injection. While specific details regarding its molecular structure are limited in public pipeline disclosures, its classification as a peptide-based immunomodulator for the nervous system strongly suggests it is a generic or biosimilar version of glatiramer acetate, a drug used to treat relapsing-remitting multiple sclerosis (RRMS). The mechanism of action for such agents typically involves modulating the immune system by acting as a decoy for myelin basic protein, competing for binding to MHC class II molecules, and shifting the T-cell profile from a pro-inflammatory to an anti-inflammatory state, thereby protecting the myelin sheath from autoimmune destruction.